Vanda Pharmaceuticals Inc. (VNDA) NASDAQ
6.23
-0.1391(-2.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.23
-0.1391(-2.19%)
Currency In USD
| Market Cap | 519.76M |
| Enterprise Value | 447.53M |
| P/E Ratio | -1.55 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.72 |
| Price/Book Ratio | 1.32 |
| Enterprise/Revenue | 1.53 |
| Enterprise/EBITDA | -2.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.1 |
| Operating Margin | -0.74 |
| Return On Assets | -0.55 |
| Return On Equity | -0.61 |
| Revenue | 216.11M |
| Revenue/Share | 3.66 |
| Gross Profit | 203.06M |
| EBITDA | -139.25M |
| Net Income | -220.47M |
| Diluted EPS | -3.74 |
| Total Cash | 202.31M |
| Total Cash/Share | 3.4 |
| Total Debt | 13.07M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.16 |
| Book Value Per Share | 4.72 |
| 52-Week Change | 44.79 |
| 52-Week High | 9.94 |
| 52-Week Low | 4.14 |
| Moving Average 50 Days | 6.82 |
| Moving Average 200 Days | 6.3 |
| Average Volume | 1.43M |
| Shares Outstanding | 60.14M |
| % Held by Institutions | 78.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |